Literature DB >> 24402695

Vitamin D and cancer: the promise not yet fulfilled.

Daniel D Bikle1.   

Abstract

The negative association of the latitude where people live and the incidence of non cutaneous cancer in that population in North America have been demonstrated in many studies for many types of cancer. Since the intensity of UVB exposure decreases with increasing latitude, and UVB exposure provides the mechanism for vitamin D production in the skin, the hypothesis that increased vitamin D provides protection against the development of cancer has been proposed. This hypothesis has been tested in a substantial number of prospective and case control studies and in a few randomized clinical trials (RTC) assessing whether either vitamin D intake or serum levels of 25 hydroxyvitamin D (25OHD) correlate (inversely) with cancer development. Most of the studies have focused on colorectal, breast, and prostate cancer. The results have been mixed. The most compelling data for a beneficial relationship between vitamin D intake or serum 25OHD levels and cancer have been obtained for colorectal cancer. The bulk of the evidence also favors a beneficial relationship for breast cancer, but the benefit of vitamin D for prostate and skin cancer in clinical populations has been difficult to demonstrate. RTCs in general have been flawed in execution or too small to provide compelling evidence one way or the other. In contrast, animal studies have been quite consistent in their demonstration that vitamin D and/or its active metabolite 1,25 dihydroxyvitamin D (1,25(OH)2D) can prevent the development and/or treat a variety of cancers in a variety of animal models. Furthermore, 1,25(OH)2D has been shown to impact a number of cellular mechanisms that would be expected to underlie its anticancer effects. Thus, there is a dilemma-animal and cellular studies strongly support a role for vitamin D in the prevention and treatment of cancer, but the clinical studies for most cancers have not yet delivered compelling evidence that the promise from preclinical studies has been fulfilled in the clinic.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24402695      PMCID: PMC3976762          DOI: 10.1007/s12020-013-0146-1

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  100 in total

1.  Tumor progression in the LPB-Tag transgenic model of prostate cancer is altered by vitamin D receptor and serum testosterone status.

Authors:  Sarah Mordan-McCombs; Theodore Brown; Wei-Lin Winnie Wang; Ann-Christin Gaupel; Joellen Welsh; Martin Tenniswood
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-27       Impact factor: 4.292

2.  Actions of vitamin D are mediated by the TLR4 pathway in inflammation-induced colon cancer.

Authors:  G Murillo; V Nagpal; N Tiwari; R V Benya; R G Mehta
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-07       Impact factor: 4.292

3.  The effects of 1,25-dihydroxyvitamin D3 on colon cancer cells depend on RhoA-ROCK-p38MAPK-MSK signaling.

Authors:  Paloma Ordóñez-Morán; Silvia Alvarez-Díaz; Noelia Valle; María Jesús Larriba; Félix Bonilla; Alberto Muñoz
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-17       Impact factor: 4.292

Review 4.  The role of vitamin D in cancer prevention and treatment.

Authors:  Aruna V Krishnan; Donald L Trump; Candace S Johnson; David Feldman
Journal:  Endocrinol Metab Clin North Am       Date:  2010-06       Impact factor: 4.741

5.  Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis.

Authors:  Li Laine Ooi; Hong Zhou; Robert Kalak; Yu Zheng; Arthur D Conigrave; Markus J Seibel; Colin R Dunstan
Journal:  Cancer Res       Date:  2010-02-16       Impact factor: 12.701

6.  Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A /sodium butyrate-induced and 5-aza-2'-deoxycytidine-induced PTEN upregulation.

Authors:  Lina Pan; Ammar F Matloob; Juan Du; Hong Pan; Zhixiong Dong; Jing Zhao; Yu Feng; Yun Zhong; Baiqu Huang; Jun Lu
Journal:  FEBS J       Date:  2010-01-18       Impact factor: 5.542

7.  Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial.

Authors:  Veronika Fedirko; Roberd M Bostick; Qi Long; W Dana Flanders; Marjorie L McCullough; Eduard Sidelnikov; Carrie R Daniel; Robin E Rutherford; Aasma Shaukat
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

8.  Meta-analysis of vitamin D, calcium and the prevention of breast cancer.

Authors:  Peizhan Chen; Pingting Hu; Dong Xie; Ying Qin; Fudi Wang; Hui Wang
Journal:  Breast Cancer Res Treat       Date:  2009-10-23       Impact factor: 4.872

9.  Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma.

Authors:  Maryam M Asgari; Jean Tang; Margaret E Warton; Mary-Margaret Chren; Charles P Quesenberry; Dan Bikle; Ronald L Horst; Norman Orentreich; Joseph H Vogelman; Gary D Friedman
Journal:  J Invest Dermatol       Date:  2009-12-31       Impact factor: 8.551

10.  Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men.

Authors:  Jean Y Tang; Neeta Parimi; Angela Wu; W John Boscardin; James M Shikany; Mary-Margaret Chren; Steven R Cummings; Ervin H Epstein; Douglas C Bauer
Journal:  Cancer Causes Control       Date:  2010-03       Impact factor: 2.506

View more
  20 in total

1.  Nonspecific binding of a frequently used vitamin D receptor (VDR) antibody: important implications for vitamin D research in human health.

Authors:  Pedro L F Costa; Monica M França; Bruno Ferraz-de-Souza
Journal:  Endocrine       Date:  2016-07-09       Impact factor: 3.633

Review 2.  Vitamin D, cancer, and dysregulated phosphate metabolism.

Authors:  Ronald B Brown
Journal:  Endocrine       Date:  2019-06-23       Impact factor: 3.633

Review 3.  The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes.

Authors:  Gerardo Sarno; Giuseppe Daniele; Giacomo Tirabassi; Alberto O Chavez; Opeolu O Ojo; Francesco Orio; Hana Kahleova; Giancarlo Balercia; William B Grant; Paride De Rosa; Annamaria Colao; Giovanna Muscogiuri
Journal:  Endocrine       Date:  2015-05-22       Impact factor: 3.633

4.  Vitamin D-binding protein: one more piece in the puzzle of acromegalic osteopathy?

Authors:  G Mazziotti; F Maffezzoni; A Giustina
Journal:  Endocrine       Date:  2016-02-22       Impact factor: 3.633

Review 5.  Modification in the diet can induce beneficial effects against breast cancer.

Authors:  Felix Aragón; Gabriela Perdigón; Alejandra de Moreno de LeBlanc
Journal:  World J Clin Oncol       Date:  2014-08-10

6.  25-Hydroxyvitamin D3 and its C-3 epimer are elevated in the skin and serum of Skh-1 mice supplemented with dietary vitamin D3.

Authors:  Matthew D Teegarden; Amanda R Campbell; Jessica L Cooperstone; Kathleen L Tober; Steven J Schwartz; Tatiana M Oberyszyn
Journal:  Mol Nutr Food Res       Date:  2017-07-20       Impact factor: 5.914

7.  The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.

Authors:  Einat Avital Schmutz; Michael Bruce Zimmermann; Sabine Rohrmann
Journal:  Eur J Nutr       Date:  2015-02-21       Impact factor: 5.614

8.  Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome.

Authors:  Eli Muchtar; Matthew T Drake; Nelson Leung; Angela Dispenzieri; Martha Q Lacy; Francis K Buadi; David Dingli; Suzanne R Hayman; Prashant Kapoor; Yi Lisa Hwa; Amie Fonder; Miriam Hobbs; Wilson Gonsalves; Taxiarchis V Kourelis; Rahma Warsame; Stephen Russell; Ronald S Go; Moritz Binder; Robert A Kyle; S Vincent Rajkumar; Shaji K Kumar; Morie A Gertz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-21       Impact factor: 6.055

Review 9.  Endogenously produced nonclassical vitamin D hydroxy-metabolites act as "biased" agonists on VDR and inverse agonists on RORα and RORγ.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Judith V Hobrath; Allen S W Oak; Edith K Y Tang; Elaine W Tieu; Wei Li; Robert C Tuckey; Anton M Jetten
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-28       Impact factor: 4.292

Review 10.  The utility of Apc-mutant rats in modeling human colon cancer.

Authors:  Amy A Irving; Kazuto Yoshimi; Marcia L Hart; Taybor Parker; Linda Clipson; Madeline R Ford; Takashi Kuramoto; William F Dove; James M Amos-Landgraf
Journal:  Dis Model Mech       Date:  2014-10-02       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.